NCT04575363View on ClinicalTrials.gov

RPSA as a Potential Prognostic Biomarker of Pancreatic Cancer

NARecruitingINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

October 18, 2021

Primary Completion Date

October 18, 2026

Study Completion Date

October 18, 2027

Conditions
Pancreatic Ductal Adenocarcinoma (PDAC)
Interventions
OTHER

Blood sample

Blood sample

Trial Locations (1)

Unknown

RECRUITING

Damien JOLLY, Reims

All Listed Sponsors
lead

CHU de Reims

OTHER